vs
Side-by-side financial comparison of RHYTHM PHARMACEUTICALS, INC. (RYTM) and SHORE BANCSHARES INC (SHBI). Click either name above to swap in a different company.
SHORE BANCSHARES INC is the larger business by last-quarter revenue ($59.1M vs $57.3M, roughly 1.0× RHYTHM PHARMACEUTICALS, INC.). On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 11.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 11.3%).
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
Shore Bancshares Inc. is a U.S. regional bank holding company headquartered in Maryland. It offers a full range of retail and commercial banking services, including deposit products, personal and commercial loans, and wealth management solutions, primarily serving local individual customers, small businesses and mid-sized enterprises in its operating regions.
RYTM vs SHBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.3M | $59.1M |
| Net Profit | $-47.5M | — |
| Gross Margin | 91.6% | — |
| Operating Margin | -82.2% | 35.2% |
| Net Margin | -83.0% | — |
| Revenue YoY | 36.9% | 11.8% |
| Net Profit YoY | -9.6% | — |
| EPS (diluted) | $-0.73 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.3M | $59.1M | ||
| Q3 25 | $51.3M | $56.4M | ||
| Q2 25 | $48.5M | $56.6M | ||
| Q1 25 | $32.7M | $53.0M | ||
| Q4 24 | $41.8M | $52.9M | ||
| Q3 24 | $33.3M | $50.5M | ||
| Q2 24 | $29.1M | $50.6M | ||
| Q1 24 | $26.0M | $47.7M |
| Q4 25 | $-47.5M | — | ||
| Q3 25 | $-52.9M | $14.3M | ||
| Q2 25 | $-46.6M | $15.5M | ||
| Q1 25 | $-49.5M | $13.8M | ||
| Q4 24 | $-43.3M | — | ||
| Q3 24 | $-43.6M | $11.2M | ||
| Q2 24 | $-32.3M | $11.2M | ||
| Q1 24 | $-141.4M | $8.2M |
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | — | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | — | ||
| Q2 24 | 89.9% | — | ||
| Q1 24 | 89.2% | — |
| Q4 25 | -82.2% | 35.2% | ||
| Q3 25 | -102.6% | 33.7% | ||
| Q2 25 | -93.4% | 36.5% | ||
| Q1 25 | -143.7% | 34.4% | ||
| Q4 24 | -98.6% | 34.3% | ||
| Q3 24 | -132.0% | 29.6% | ||
| Q2 24 | -139.2% | 29.7% | ||
| Q1 24 | -538.7% | 22.2% |
| Q4 25 | -83.0% | — | ||
| Q3 25 | -103.1% | 25.5% | ||
| Q2 25 | -96.1% | 27.4% | ||
| Q1 25 | -151.4% | 26.0% | ||
| Q4 24 | -103.6% | — | ||
| Q3 24 | -131.2% | 22.1% | ||
| Q2 24 | -110.9% | 22.2% | ||
| Q1 24 | -544.4% | 17.2% |
| Q4 25 | $-0.73 | $0.48 | ||
| Q3 25 | $-0.82 | $0.43 | ||
| Q2 25 | $-0.75 | $0.46 | ||
| Q1 25 | $-0.81 | $0.41 | ||
| Q4 24 | $-0.71 | $0.39 | ||
| Q3 24 | $-0.73 | $0.34 | ||
| Q2 24 | $-0.55 | $0.34 | ||
| Q1 24 | $-2.35 | $0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $388.9M | $355.6M |
| Total DebtLower is stronger | — | $89.1M |
| Stockholders' EquityBook value | $139.1M | $589.9M |
| Total Assets | $480.2M | $6.3B |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $388.9M | $355.6M | ||
| Q3 25 | $416.1M | $416.5M | ||
| Q2 25 | $291.0M | $185.0M | ||
| Q1 25 | $314.5M | $389.0M | ||
| Q4 24 | $320.6M | $459.9M | ||
| Q3 24 | $298.4M | $183.6M | ||
| Q2 24 | $319.1M | $138.9M | ||
| Q1 24 | $201.2M | $114.6M |
| Q4 25 | — | $89.1M | ||
| Q3 25 | — | $74.5M | ||
| Q2 25 | — | $74.2M | ||
| Q1 25 | — | $74.0M | ||
| Q4 24 | — | $73.7M | ||
| Q3 24 | — | $123.5M | ||
| Q2 24 | — | $122.8M | ||
| Q1 24 | — | $72.6M |
| Q4 25 | $139.1M | $589.9M | ||
| Q3 25 | $148.8M | $577.2M | ||
| Q2 25 | $-11.9M | $565.2M | ||
| Q1 25 | $18.9M | $552.5M | ||
| Q4 24 | $21.7M | $541.1M | ||
| Q3 24 | $11.2M | $533.3M | ||
| Q2 24 | $39.3M | $522.8M | ||
| Q1 24 | $61.6M | $515.2M |
| Q4 25 | $480.2M | $6.3B | ||
| Q3 25 | $506.9M | $6.3B | ||
| Q2 25 | $372.7M | $6.0B | ||
| Q1 25 | $386.7M | $6.2B | ||
| Q4 24 | $392.3M | $6.2B | ||
| Q3 24 | $363.6M | $5.9B | ||
| Q2 24 | $381.8M | $5.9B | ||
| Q1 24 | $258.7M | $5.8B |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.4M | $62.4M |
| Free Cash FlowOCF − Capex | — | $59.2M |
| FCF MarginFCF / Revenue | — | 100.2% |
| Capex IntensityCapex / Revenue | — | 5.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $110.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.4M | $62.4M | ||
| Q3 25 | $-26.6M | $42.5M | ||
| Q2 25 | $-23.3M | $-8.3M | ||
| Q1 25 | $-40.4M | $19.8M | ||
| Q4 24 | $-18.8M | $46.9M | ||
| Q3 24 | $-25.2M | $9.1M | ||
| Q2 24 | $-29.1M | $3.0M | ||
| Q1 24 | $-40.7M | $2.4M |
| Q4 25 | — | $59.2M | ||
| Q3 25 | — | $41.9M | ||
| Q2 25 | — | $-9.2M | ||
| Q1 25 | — | $18.8M | ||
| Q4 24 | — | $41.7M | ||
| Q3 24 | — | $8.4M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $614.0K |
| Q4 25 | — | 100.2% | ||
| Q3 25 | — | 74.3% | ||
| Q2 25 | — | -16.3% | ||
| Q1 25 | — | 35.4% | ||
| Q4 24 | — | 78.8% | ||
| Q3 24 | — | 16.7% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 9.9% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 3.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | -0.54× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.81× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
